Replies to post #1066 on Conatus Pharmaceuticals Inc. (CNAT)

[Inoviorulez]

OH I agree with u. I am not too worried. I know that the coming ad hoc data if statistically significant could carry the stock to $15 per share instantly. In addition Q2 is when the phase 2b LC trial is expected to start and novartis can choose option to license the drug.